Linneo Health
Gerardo Gorostiza serves as the CFO and Chief Financial and Strategy Officer at Linneo Health since June 2022, overseeing multiple departments including Strategy, IT, Purchasing, ESG, and Legal for a leading global manufacturer and supplier of medicinal cannabis. Prior to this role, Gerardo held the position of CEO at Grupo Juan Luna from February 2019 to June 2022, where the focus was on specialized cheese processing and high-quality cured pork products. Earlier experience includes various strategic and financial leadership roles at ADVEO, COEMAC, and Uralita, as well as consulting positions at PwC and Bull. Gerardo has advanced educational qualifications, including an eMBA from IE Business School and courses in Investor Relations and Private Equity from Instituto BME and Università Bocconi.
This person is not in any teams
Linneo Health
1 followers
Linneo Health is a Europe based global leader in the research, cultivation and supply of cannabis to improve human health and wellbeing. As the world’s only vertically integrated medicinal cannabis supplier, no other company has our 90-year heritage in the manufacturing and movement of controlled substances. We are optimally positioned to address the needs of our customers through every stage of product development, regulation and handling. We are setting the benchmark for standards and customer service in medicinal cannabis. Through ongoing investment in one of the most advanced quality control laboratories in Europe, and by applying industry-leading cultivation techniques, we are the trusted partner to address the needs of customers today and, with significant expansion capabilities, the demands of tomorrow. With an unrivalled focus on quality and driven by the firm belief that people around the world deserve to be treated with cannabis medicine of the highest standard, we bring cutting edge innovation in medicinal cannabis to partners, to deliver better patient outcomes and improve lives.